CIK 0001635088
- Large accelerated filer
Roivant Sciences Ltd.
Sign in to watch- Ticker
- ROIV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- Bermuda
- Entity type
- Operating
- EIN
- 981173944
- Phone
- +44 12955950
- Business address
- 7TH FLOOR, 50 BROADWAY, LONDON, United Kingdom, SW1H 0DB
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $70,369,463
- in 12 filings, $45.5M under 10b5-1 plans
Net −$70,369,463. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-07-20 | Kumar Rakhi Chief Accounting Officer | Shares withheld for taxes 10b5-1 | −958 | $11.00 | $11K | 213,367 |
| 2024-07-20 | Venker Eric President & COO | Shares withheld for taxes 10b5-1 | −10,945 | $11.00 | $120K | 446,307 |
| 2024-06-28 | Pulik Richard CFO | Shares withheld for taxes 10b5-1 | −2,340 | $10.57 | $25K | 290,434 |
| 2024-06-20 | Pulik Richard CFO | Shares withheld for taxes 10b5-1 | −2,129 | $10.80 | $23K | 290,572 |
| 2024-06-20 | Kumar Rakhi Chief Accounting Officer | Shares withheld for taxes 10b5-1 | −3,087 | $10.80 | $33K | 212,123 |
| 2024-06-20 | Venker Eric President & COO | Shares withheld for taxes 10b5-1 | −10,945 | $10.80 | $118K | 457,252 |
| 2024-06-20 | Gline Matthew CEO | Shares withheld for taxes 10b5-1 | −10,945 | $10.80 | $118K | 1,131,816 |
| 2024-05-28 | Pulik Richard CFO | Shares withheld for taxes 10b5-1 | −2,341 | $10.83 | $25K | 292,701 |
| 2024-05-20 | Venker Eric President & COO | Shares withheld for taxes 10b5-1 | −16,003 | $11.37 | $182K | 468,197 |
| 2024-05-20 | Kumar Rakhi Chief Accounting Officer | Shares withheld for taxes 10b5-1 | −1,363 | $11.37 | $15K | 215,210 |
| 2024-05-20 | Gline Matthew CEO | Shares withheld for taxes 10b5-1 | −10,945 | $11.37 | $124K | 1,142,761 |
| 2024-04-28 | Pulik Richard CFO | Shares withheld for taxes 10b5-1 | −2,340 | $11.03 | $26K | 295,042 |
| 2024-04-24 | Oren Ilan Director | Grant or award 10b5-1 | +2,121 | 80,463 | ||
| 2024-04-24 | Oren Ilan Director | Shares withheld for taxes 10b5-1 | −54 | $10.90 | $589 | 80,409 |
| 2024-04-24 | MOMTAZEE JAMES C Director | Grant or award 10b5-1 | +1,490 | 77,829 | ||
| 2024-04-24 | MOMTAZEE JAMES C Director | Shares withheld for taxes 10b5-1 | −293 | $10.90 | $3K | 77,536 |
| 2024-04-24 | Fitzgerald Meghan Director | Grant or award 10b5-1 | +1,261 | 13,947 | ||
| 2024-04-24 | Fitzgerald Meghan Director | Shares withheld for taxes 10b5-1 | −83 | $10.90 | $905 | 13,864 |
| 2024-04-24 | Epperly Melissa B, Director | Grant or award 10b5-1 | +1,146 | 22,684 | ||
| 2024-04-24 | Epperly Melissa B, Director | Shares withheld for taxes 10b5-1 | −123 | $10.90 | $1K | 22,561 |
Page 31 of 38 · 748 trades